Ampio Pharmaceuticals Inc (AMPE)

0.57
0.01 2.70
AMEX : Health Care
Prev Close 0.56
Open 0.56
Day Low/High 0.53 / 0.58
52 Wk Low/High 0.84 / 4.32
Volume 237.03K
Avg Volume 504.90K
Exchange AMEX
Shares Outstanding 68.23M
Market Cap 37.53M
EPS -0.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Ampio Pharmaceuticals Provides Corporate Update

Engages Locust Walk as Strategic Advisor

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

TheStreet's biotech columnist offers his own report card on biotech stocks.

Notable Monday Option Activity: AMPE, STRP, ENVA

Notable Monday Option Activity: AMPE, STRP, ENVA

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Ampio Pharmaceuticals Inc , where a total of 1,453 contracts have traded so far, representing approximately 145,300 underlying shares. That amounts to about 81.2% of AMPE's average daily trading volume over the past month of 179,045 shares.

7 Stocks Under $10 That Could Make You a Lot of Money

7 Stocks Under $10 That Could Make You a Lot of Money

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Ampio Pharmaceuticals (AMPE) Weak On High Volume Today

Ampio Pharmaceuticals (AMPE) Weak On High Volume Today

Trade-Ideas LLC identified Ampio Pharmaceuticals (AMPE) as a weak on high relative volume candidate

Why Ampio Pharma (AMPE) Stock Is Plummeting Today

Why Ampio Pharma (AMPE) Stock Is Plummeting Today

Ampio Pharma (AMPE) stock is sharply lower this afternoon following a phase 3 trial for its osteoarthritis pain treatment.

Ampio Pharmaceuitcals (AMPE) Stock Spikes After Receiving FDA Special Protocol Assessment

Ampio Pharmaceuitcals (AMPE) Stock Spikes After Receiving FDA Special Protocol Assessment

Ampio Pharmaceuticals (AMPE) shares are up over 10% after the company received Special Protocol Assessment from the FDA.

ALERT: The Rosen Law Firm Reminds Ampio Pharmaceuticals, Inc. Investors Of Important Deadline

ALERT: The Rosen Law Firm Reminds Ampio Pharmaceuticals, Inc. Investors Of Important Deadline

The Rosen Law Firm reminds purchasers of Ampio Pharmaceuticals, Inc.

Short Interest In Ampio Pharmaceuticals Declines 17.8%

Short Interest In Ampio Pharmaceuticals Declines 17.8%

The most recent short interest data has been released by the NASDAQ for the 04/30/2015 settlement date, which shows a 1,771,994 share decrease in total short interest for Ampio Pharmaceuticals Inc. , to 8,185,303, a decrease of 17.80% since 04/15/2015.

EQUITY ALERT: The Rosen Law Firm Files Securities Class Action Against Ampio Pharmaceuticals, Inc.

EQUITY ALERT: The Rosen Law Firm Files Securities Class Action Against Ampio Pharmaceuticals, Inc.

The Rosen Law Firm announces that it has filed a class action lawsuit on behalf of purchasers of Ampio Pharmaceuticals, Inc.

Biotech Stock Mailbag: Biotech Bull So Insanely Good It Will Make You Forget Week's Pain

Biotech Stock Mailbag: Biotech Bull So Insanely Good It Will Make You Forget Week's Pain

Biotech columnist Adam Feuerstein answers readers' questions about health care.

EQUITY ALERT: The Rosen Law Firm Announces Investigation Of Securities Claims Against Ampio Pharmaceuticals, Inc.

EQUITY ALERT: The Rosen Law Firm Announces Investigation Of Securities Claims Against Ampio Pharmaceuticals, Inc.

The Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of investors of Ampio Pharmaceuticals, Inc.

Today's Weak On High Volume Stock: Ampio Pharmaceuticals (AMPE)

Today's Weak On High Volume Stock: Ampio Pharmaceuticals (AMPE)

Trade-Ideas LLC identified Ampio Pharmaceuticals (AMPE) as a weak on high relative volume candidate

Ampio Pharmaceuticals (AMPE) Stock Tanks Today after Treatment Fails To Reach Primary Endpoint

Ampio Pharmaceuticals (AMPE) Stock Tanks Today after Treatment Fails To Reach Primary Endpoint

Ampio Pharmaceuticals (AMPE) shares have lost nearly two-thirds of their value after announcing weak results from its phase III study of pain reliever Ampion.

Strong On High Volume: Ampio Pharmaceuticals (AMPE)

Strong On High Volume: Ampio Pharmaceuticals (AMPE)

Trade-Ideas LLC identified Ampio Pharmaceuticals (AMPE) as a strong on high relative volume candidate

AMPE June 19th Options Begin Trading

AMPE June 19th Options Begin Trading

Investors in Ampio Pharmaceuticals Inc. saw new options begin trading today, for the June 19th expiration.